Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Specialty Process Labs LLC

US Class II Ongoing · initiated 2026-01-16

Subpotent Drug

McKesson

US Class I Ongoing · initiated 2026-01-16

Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the …

Greenstone Llc

US Class II Ongoing · initiated 2026-01-15

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information whe…

Amerisource Health Services LLC

US Class II Ongoing · initiated 2026-01-14

Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

Octreotide for injectable suspension

Canada Type I Ongoing · initiated 2026-01-13

Product quality. If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement prod…

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2026-01-12

Superpotent and Subpotent

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2026-01-12

Superpotent and Subpotent

Locametz powder for solution, kit

Canada Type III Ongoing · initiated 2026-01-12

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Graviti Pharmaceuticals Private Limited

US Class II Ongoing · initiated 2026-01-10

Presence of Foreign Substance

Encon Safety Products Co

US Class II Ongoing · initiated 2026-01-06

cGMP deviations.

JAMP-ASA 81 mg EC

Canada Type II Ongoing · initiated 2026-01-05

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Cipla USA, Inc.

US Class II Ongoing · initiated 2026-01-02

Presence of Particulate Matter.

AvKARE

US Class II Ongoing · initiated 2025-12-31

Out of specification for dissolution.

Alvogen, Inc

US Class II Ongoing · initiated 2025-12-31

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited

US Class II Ongoing · initiated 2025-12-31

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2025-12-30

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling…

SUN PHARMACEUTICAL INDUSTRIES INC

US Class III Ongoing · initiated 2025-12-30

Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-12-30

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles

US Class II Ongoing · initiated 2025-12-27

Incorrect Product Formulation: product did not contain insulin as listed in the label.